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OBJECTIVES In our institute, internal mammary arteries (IMAs) have been preferred for coronary artery
bypass grafting (CABG) in diabetic patients. The purpose of this study was to evaluate the
influence of diabetes and IMA grafting on survival after CABG.
BACKGROUND The influence of diabetes on the results of CABG is not well documented, and there is
controversy about whether the use of IMAs conveys greater survival benefits to diabetic
patients.
METHODS A total of 420 consecutive patients who underwent CABG from April 1990 to July 1998 were
reviewed; 211 of these patients had diabetes mellitus at the time of surgery. Internal
mammary artery grafts have been used with increasing frequency, and bilateral IMAs have
been used when possible since 1993. Internal mammary artery grafts were used in 164
nondiabetic patients (78%) and in 155 diabetic patients (73%). Seventy-eight nondiabetic
patients and 74 diabetic patients received bilateral IMA grafts.
RESULTS The postoperative mortality was 2.4% in the nondiabetic and 2.8% in the diabetic group.
With regard to postoperative complications, diabetic patients had a significantly higher rate
of chest wound infection (p , 0.05), irrespective of whether IMAs were used or not. The use
of bilateral IMAs did not increase the risk of chest wound infection in nondiabetic or diabetic
patients. Overall survival curve, cardiac death–free curve and cardiac event–free curve were not
affected adversely by diabetes, and in diabetic patients, CABG with saphenous veins alone
conveyed significantly (p , 0.01) less long-term benefit than did CABG with at least one
IMA graft.
CONCLUSIONS It was suggested that IMA grafts should be preferred in diabetic patients. (J Am Coll Cardiol
1999;34:532–8) © 1999 by the American College of Cardiology
The influence of diabetes on outcome after coronary artery
bypass grafting (CABG) is not well defined. The results of
previous studies are conflicting, reporting either no effect
(1,2) or adverse (3,4) effects of diabetes on the early and
long-term results after CABG. Recently, the importance of
internal mammary artery (IMA) use for CABG in diabetic
patients has been reported (5). The IMA has been estab-
lished as the preferred conduit for CABG. However, IMA
use in diabetic patients may increase the risk of sternal
infections. In our institute, IMAs have been preferred for
CABG in diabetic patients because the patients usually have
diffuse coronary artery disease involving distal vessels (6),
and saphenous vein grafts to such vessels may not remain
patent. Furthermore, we have used bilateral IMAs whenever
possible since 1993, although many authors reported that
the use of bilateral IMAs should be avoided in diabetic
patients because of prevalence of chest wound infection (7).
This report is a retrospective comparative study of our
recent CABG surgery for patients with, or without, diabetes
mellitus. Particular attention was given to operative mor-
bidity when IMAs were used.
METHODS
Between April 1990 and July 1998, 420 consecutive patients
who underwent CABG had their charts reviewed. Patients
with valvular heart disease requiring valve repair or replace-
ment, postinfarction ventricular septal perforation or con-
genital heart disease were excluded. At the time of surgery,
211 patients (50%) had diabetes mellitus that had been
diagnosed by the endoclinologists at our Tokyo Saiseikai
diabetic center. Patients were defined as diabetic based upon
the standard published criteria, having fasting serum glucose
equal to or greater than 140 mg/dl. Of these patients, 96
(45%) were being treated with insulin and 58 (27%) with
oral hypoglycemic medications.
Indications for CABG were based on standard clinical
and angiographic criteria. Grafting was attempted on all
vessels 1.5 mm or greater in diameter with 75% or greater
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obstruction. Coronary endarterectomy was generally
avoided. All operations were undertaken through median
sternotomy. Cardiopulmonary bypass was conducted under
moderate hypothermia with antegrade crystalloid cardiople-
gia. Both proximal and distal anastomoses were performed
during a single period of aortic occlusion. Internal mam-
mary artery grafts have been used with increasing frequency,
and bilateral IMAs have been used when possible since
1993. Right IMAs were used for the revascularization of left
anterior descending arteries anterior to the heart, left
circumflex arteries through the transverse sinus and right
coronary arteries as pedicled or free grafts. Diabetes was not
a reason for excluding the use of IMAs.
With regard to operative complications, myocardial in-
farctions were determined by persistent creatine phosphoki-
nase, MB fraction enzyme elevations, new Q waves, or ST
elevation on electrocardiograms. Arrhythmias were defined
as complications if they were considered life-threatening or
required medication. Wounds were defined as being in-
fected if purulent material was discharged from the wound,
with or without a positive culture. Minor chest wound
infections included those infections limited to the subcuta-
neous tissues. Major chest wound infections included all
cases where tissues were infected down to the sternal wire or
beyond, and which required reexploration and refixation of
the sternum. Leg wound infections were not stratified based
on depth of infectious involvement. Strokes were diagnosed
from physical findings and documented using brain com-
puterized tomography. Respiratory failure was recorded for
all patients who required mechanical ventilatory support for
more than 48 h.
Follow-up data were obtained from each patient’s hospi-
tal record. The data were completely reviewed in 93% of the
patients.
Limitations. This study is a nonrandomized retrospective
study. Fewer patients with saphenous vein grafts alone
underwent CABG during the earlier period than patients
with IMA grafts. Furthermore, bilateral IMAs were used
for CABG since 1993.
Data analysis. The differences between the nondiabetic
and diabetic groups in preoperative characteristics were
tested for statistical significance by t and chi-square tests
as appropriate. Survival curves were estimated using the
Kaplan–Meier method. The relationships between dis-
crete risk factors to survival were investigated with
log-rank tests.
RESULTS
The differences between the nondiabetic and diabetic pa-
tient groups in age, gender, anatomic extent of coronary
lesions, left ventricular ejection fraction, preoperative use of
intra-aortic balloon pumping, frequency of urgent opera-
tions, history of old myocardial infarction, history of the
previous CABG and presence of cerebrovascular complica-
tions are shown in Table 1. The preoperative baseline
characteristics were similar in the nondiabetic and diabetic
patient groups, and there was no statistically significant
difference.
Arterial grafts were used in 323 patients (77%). A single
IMA was used in 86 nondiabetic and 81 diabetic patients.
Bilateral IMAs were used in 78 nondiabetic and 74 diabetic
patients. Other than IMAs, right gastroepiploic arteries
were used as arterial conduits in 21 nondiabetic and 15
diabetic patients. The differences in the conduits used for
coronary revascularization between the nondiabetic and
diabetic patient groups are shown in Table 2. The mean
number of distal anastomoses was 3.0 (range 1 to 7) in the
nondiabetic and 3.2 (range 1 to 6) in the diabetic patient
group. The mean aortic cross-clamp time was 110 (range 27
to 226) min in the nondiabetic and 116 (range 24 to 220)
min in the diabetic patient group. These operative variables
were remarkably similar.
There were five operative deaths in the nondiabetic and
six in the diabetic patients. The postoperative mortality was
2.4% in the nondiabetic and 2.8% in the diabetic patients,
Abbreviations and Acronyms
CABG 5 coronary artery bypass grafting
IMA 5 internal mammary artery
Table 1. Preoperative Patient Characteristics
Nondiabetic Group Diabetic Group
Number of patients 209 211
Age (yr)
Range 32–84 30–84
Mean 63.9 64.0
Gender
Male 164 (78%) 154 (73%)
Female 45 (22%) 57 (27%)
Coronary lesion
LMT 47 (22%) 48 (23%)
3VD 102 (49%) 118 (56%)
2VD 30 (14%) 39 (18%)
1VD 30 (14%) 6 (3%)
LVEF
Range 14–83 10–90
Mean 50.8 47.6
Preoperative IABP 59 (28%) 60 (28%)
Urgent operation 40 (19%) 43 (20%)
OMI 149 (71%) 170 (81%)
Previous CABG 8 (4%) 9 (4%)
CVD 69 (33%) 75 (36%)
1VD 5 one-vessel disease; 2VD 5 two-vessel disease; 3VD 5 three-vessel disease;
CABG 5 coronary artery bypass grafting; CVD 5 cerebrovascular disease; IABP 5
intra-aortic balloon pumping; LMT 5 left main trunk disease; LVEF 5 left
ventricular ejection fraction; OMI 5 old myocardial infarction.
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respectively, and the difference in mortality was not signif-
icant. The causes of operative death are shown in Table 3.
The operative complications and their rates are shown in
Table 4 for nondiabetic and diabetic patients. Diabetic
patients had a significantly higher rate of chest wound
infection (p , 0.05). It was then analyzed whether there
were significant associations between the occurrence of
chest wound infection and conduits used (Table 5). The
incidence of chest wound infection was not different irre-
spective of whether IMAs were used or not, and the use of
bilateral IMAs did not increase the risk of chest wound
infection in nondiabetic or diabetic patients.
The angiographic investigations conducted at about 3
weeks after surgery in 395 patients showed that the graft
patency rate was 93.9% in nondiabetic and 96.3% in diabetic
patients, respectively. The patency rate of IMA grafts was
98.7% in nondiabetic patients and 96.6% in diabetic pa-
tients. There was no difference in the graft patency rate
between nondiabetic and diabetic patients. In the nondia-
betic group, the IMAs had a higher patency rate than the
saphenous veins (p , 0.05).
Overall survival curves and cardiac death–free curves for
the nondiabetic and diabetic patients were compared for the
entire population (Fig. 1). When cardiac death, acute
myocardial infarction, coronary intervention and reopera-
tion for coronary ischemia were included as cardiac events,
cardiac event–free curves were also compared between these
groups (Fig. 1). In each comparison, no adverse effects of
diabetes were apparent. With regard to conduits used for
coronary revascularization, the overall survival curves, car-
diac death–free curves and cardiac event–free curves dem-
onstrated that IMA grafts conferred no long-term benefit to
nondiabetic patients (Fig. 2). However, diabetic patients
who underwent CABG with at least one IMA graft received
more benefit than those who had only saphenous veins. This
difference was statistically significant (p , 0.01) (Fig. 3).
The benefit of the bilateral use of IMAs, however, was not
apparent in nondiabetic or diabetic patients.
DISCUSSION
Operative mortality. It remains unclear whether or not
diabetes mellitus is associated with increased operative
Table 2. Conduits Used for Coronary Revascularization
Nondiabetic
Group
Diabetic
Group
Number of patients 209 211
Single IMA
Number 86 81
% 41% 38%
Bilateral IMAs
Number 78 74
% 37% 35%
GEA
Number 21 15
% 10% 7%
Saphenous veins only
Number 45 52
% 22% 25%
GEA 5 right gastroepiploic artery; IMA 5 internal mammary artery.
Table 3. Causes of Operative Death
Nondiabetic
Group
Diabetic
Group
Stroke 1 2
Myocardial infarction 1 1
Pulmonary embolism 2
Mediastinitis 1
Subarachnoidal hemorrhage 1
Superior mesenteric artery embolism 1
Respiratory failure 1
Table 4. Operative Morbidity
Nondiabetic Group Diabetic Group
Number
Percent of
Operations Number
Percent of
Operations
Chest wound infection
Minor 8 3.8 17 8.1*
Major 4 1.9 4 1.9
Leg wound infection 5 2.4 1 0.5
Arrhythmia 6 2.8 2 1.0
Stroke 3 1.4 6 2.9
Reexploration for bleeding 3 1.4 5 2.4
Myocardial infarction 1 0.5 2 1.0
Respiratory failure 4 1.9 3 1.4
SMA embolism 2 0.9 0 0
Cholecystitis 2 0.9 0 0
Others 4 1.9 2 1.0
*The difference of rate was statistically significant (p , 0.05).
SMA 5 superior mesenteric artery.
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mortality in patients undergoing CABG. Morris et al.
analyzed a large series of diabetic patients undergoing
CABG and demonstrated that diabetes was a significant,
independent risk factor and that the use of IMA grafts
conferred a significant survival benefit (3). In the analysis by
Cosgrove et al. (7) of 8,000 patients undergoing CABG
surgery, diabetes did not emerge as a predictor of operative
mortality. Other studies have shown that diabetes does not
increase the operative mortality, although the long-term
mortality appears to be increased (8,9). In our study, there
was no significant difference in operative mortality between
nondiabetic and diabetic patients, and no adverse effects of
diabetes were apparent from the overall survival curve, the
cardiac death–free curve or the cardiac event–free curve.
Effects of using IMAs. In our institute, diabetes has not
been a reason to refuse using IMAs for coronary revascu-
larization. Bilateral IMAs have been used whenever possi-
ble, even in diabetic patients, since 1993. At least one IMA
graft was used in 73% of diabetic patients, and 48% of them
received bilateral IMAs grafting. The rates were similar in
nondiabetic patients. In the recent Bypass Angioplasty
Figure 1. Overall survival curves, cardiac death–free curves and cardiac event–free curves were compared by using the Kaplan–Meier
method between nondiabetic and diabetic patients. DM 5 diabetes mellitus.
Table 5. Conduits Used for Coronary Revascularization and Occurrence of Chest
Wound Infections
Nondiabetic Group Diabetic Group
Minor Major Minor Major
Saphenous veins alone 2/45 2/45 8/52 1/52
(4.4%) (4.4%) (15%) (1.9%)
Single IMA 3/86 2/86 6/81 1/81
(3.5%) (2.3%) (7.4%) (1.2%)
Bilateral IMAs 3/78 0/78 3/74 2/74
(3.8%) (0%) (4.1%) (2.7%)
IMA 5 internal mammary artery.
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Revascularization Investigation study, it was demonstrated
that in diabetic patients, the relation of the presence of an
IMA graft to cardiac mortality was particularly striking and
that the survival benefit of CABG was limited to the use of
IMA grafts (5). Diffuse coronary artery disease involving
distal vessels is usually more common in diabetic patients,
although it was not quantitated in our study. These angio-
graphic characteristics of coronary arteries in diabetic pa-
tients may affect the relative benefit attributable to IMA
grafting. The present study demonstrated the long-term
benefit of IMA use in diabetic patients (Fig. 2 and 3).
Therefore not only the early results but also the long-term
results of our CABG surgery in diabetic patients were
comparable with those in nondiabetic patients. This out-
come may be attributed to our aggressive use of IMA grafts.
Morris et al. described the importance of IMA use in
diabetic patients, but they used IMA grafts in 67% of their
diabetic patients. In our study, 73% of diabetic patients
underwent CABG using at least one IMA, and about half
of them received bilateral IMAs grafting. The rate of IMA
use in our study was considered to be high, and the
frequency of bilateral IMAs use was considered to be
exceedingly high among the recent reports.
Operative morbidity. Many authors have reported in-
creased morbidity in diabetic patients (10,11). Among the
postoperative complications, chest wound infections are of
great concern to surgeons, especially when IMA grafts are
used, because dissection of the IMA would devascularize the
sternum (12). In our study, the rate of chest wound infection
was 5.7% in nondiabetic and 10.0% in diabetic patients. The
rate of minor chest wound infection was 8.1% in diabetic
patients and was significantly higher than 3.8% in nondia-
betic patients, although the rate of major chest wound
infection that required reexploration and refixation of the
sternum was not significantly different in the two groups.
Higher infection rates in diabetic patients after CABG have
been documented previously. Fietsam et al. reported that
the rate of wound infection was 7.5% in diabetic versus
0.89% in nondiabetic subjects (10). Farrington et al. found
that 19% of diabetic patients had major chest wound
infection, compared with 2% of nondiabetic patients (11).
Furthermore, the prevalence of chest wound infection in
patients receiving bilateral IMAs grafting has been of great
concern to surgeons because devascularization of the ster-
num would be more severe than in patients receiving single
IMA grafting. In our study, the rate of chest wound
Figure 2. Overall survival curves, cardiac death–free curves and cardiac event–free curves in nondiabetic patients were compared according
to conduits used for coronary revascularization. Internal mammary artery (IMA) grafts conferred no long-term benefit to nondiabetic
patients.
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infection was not significantly different for single IMA,
bilateral IMAs or saphenous veins alone, as shown in Table
5. These results were similar to those reported by Galbut et
al. (13). The similar frequency of chest wound infection
among patients who received no, single or bilateral IMAs in
the present series may reflect our effective hemostasis and
drainage around the area from which the IMAs were
harvested. We suggest that the avoidance of hyperglycemia
during the postoperative period and close observation of and
infection control for the chest wound can protect against
major sternal infections in diabetic patients.
Conclusions. Although the bilateral use of IMAs was no
more beneficial than the single use of IMAs in the present
study, the follow-up for a longer period may demonstrate
better outcomes from the bilateral use of IMAs than from
single use in diabetic patients.
It was obvious that the rate of chest wound infection was
higher in diabetic patients, but the rate did not increase by
using IMA grafts. We suggest that IMA grafts should be
used in diabetic patients because of their excellent ability to
remain patent for a long time.
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